CO2 Laser in the Treatment of the GSM – (Genitourinary Syndrome of Menopause) Genitourinary Syndrome of Menopause
Condition(s):Menopause; Vaginal Atrophy; Urinary IncontinenceLast Updated:September 9, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Menopause; Vaginal Atrophy; Urinary IncontinenceLast Updated:September 9, 2020Completed
Condition(s):Menopause SyndromeLast Updated:January 3, 2023Completed
Condition(s):Genitourinary Syndrome of MenopauseLast Updated:November 21, 2023Completed
Condition(s):Genitourinary Syndrome of MenopauseLast Updated:February 6, 2023Recruiting
Condition(s):Genitourinary Syndrome of MenopauseLast Updated:November 13, 2023Completed
Condition(s):Genitourinary Syndrome of MenopauseLast Updated:August 14, 2019Completed
Condition(s):Cervical Carcinoma; Dyspareunia; Endometrial Carcinoma; Ovarian Carcinoma; Vaginal Carcinoma; Vaginal Dryness; Vulvar CarcinomaLast Updated:April 22, 2022Completed
Condition(s):Postmenopausal Atrophic Vaginitis; Postmenopausal Symptoms; Genitourinary SymptomsLast Updated:September 14, 2023Enrolling by invitation
Condition(s):Atrophy;VaginalLast Updated:June 23, 2023Recruiting
Condition(s):Genitourinary Syndrome of MenopauseLast Updated:March 26, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.